Notice ID: 32077ca1ef804bf7a045b7e942833a48Solicitation
Midazolam Autoinjectors Project Bioshield
Archived on August 14, 2021. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 4:00 PM UTC−04:00
- Posted
- July 15, 2021
- Notice type
- Solicitation
- NAICS
- 541714: Research and Development in Biotechnology (except Nanobiotechnology)
- Agency
- Department of Health and Human ServicesOFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE
Notice details
- Office
- ASPR BARDA DIV CONTRACTS MGMT & ACQ
- Last updated
- Sep 9, 2025
Identifiers
- Solicitation number
- 75A50121R00003
- Notice ID
- 32077ca1ef804bf7a045b7e942833a48
Description
This Request for Proposal (RFP) covers the advanced research and development, procurement, and delivery of adult and pediatric midazolam autoinjectors that have received FDA approval for the treatment of status epilepticus seizures (including seizures caused by nerve agents) in adult and pediatric populations (2+ years of age). Please see attached RFP for additional details.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
75A50121R00003- Pre-Solicitation
- Solicitation
Award typically follows within 30–90 days after the response deadline. (estimate)
- Pre-SolicitationOct 22, 2020
Midazolam Autoinjectors Project Bioshield
- 3×SolicitationCurrentJun 17, 2021
Midazolam Autoinjectors Project Bioshield
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
75A50121R00003
Archive Date
Aug 14, 2021
Office Address
Washington, DC, 20515